First Premier Bank Organon & Co. Transaction History

First Premier Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$23.31 - $28.61 $582 - $715	-25 Reduced 51.02%	24 $1,000
Q2 2022 Jul 26, 2022	BUY	$31.66 - $38.9 $1,551 - $1,906	49 New	49 $2,000
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $5,328 - $6,888	-175 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$28.63 - $35.64 $76,327 - $95,016	-2,666 Reduced 93.84%	175 $6,000
Q2 2021 Jul 14, 2021	BUY	$28.45 - $38.0 $80,826 - $107,958	2,841 New	2,841 $85,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

Stay updated on First Premier Bank with notifications on news.